Lloyd G. Mitchell

1.6k total citations
33 papers, 1.3k citations indexed

About

Lloyd G. Mitchell is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Lloyd G. Mitchell has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Lloyd G. Mitchell's work include RNA Interference and Gene Delivery (10 papers), RNA Research and Splicing (7 papers) and RNA modifications and cancer (6 papers). Lloyd G. Mitchell is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), RNA Research and Splicing (7 papers) and RNA modifications and cancer (6 papers). Lloyd G. Mitchell collaborates with scholars based in United States, Austria and United Kingdom. Lloyd G. Mitchell's co-authors include Mariano A. García-Blanco, M. Puttaraju, S. Gary Mansfield, Carl R. Merril, Jonathan Cohn, Sharon F. Jamison, John F. Engelhardt, Xiaoming Liu, Hengjun Chao and Jolanta Kole and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Lloyd G. Mitchell

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd G. Mitchell United States 19 906 348 149 98 93 33 1.3k
Richard G. James United States 25 1.4k 1.6× 360 1.0× 95 0.6× 83 0.8× 173 1.9× 46 2.1k
Marguerite Mangin United States 20 1.4k 1.5× 235 0.7× 80 0.5× 40 0.4× 172 1.8× 23 2.1k
Stephanie Groos Germany 23 740 0.8× 143 0.4× 314 2.1× 76 0.8× 168 1.8× 45 1.6k
Fernando Segade United States 24 653 0.7× 282 0.8× 149 1.0× 45 0.5× 180 1.9× 42 1.3k
Tjadine M. Holling Netherlands 15 871 1.0× 203 0.6× 61 0.4× 141 1.4× 33 0.4× 20 1.5k
Paola Corti Italy 21 512 0.6× 149 0.4× 230 1.5× 213 2.2× 104 1.1× 65 1.4k
Christopher F. Graham United Kingdom 21 1.0k 1.2× 490 1.4× 91 0.6× 25 0.3× 66 0.7× 27 1.6k
Rutger W. W. Brouwer Netherlands 20 1.2k 1.3× 298 0.9× 58 0.4× 55 0.6× 142 1.5× 56 1.8k
Louise M. C. Webb United Kingdom 21 467 0.5× 143 0.4× 193 1.3× 111 1.1× 68 0.7× 28 1.8k
Kieran M. Short Australia 23 1.1k 1.2× 250 0.7× 141 0.9× 31 0.3× 275 3.0× 38 1.7k

Countries citing papers authored by Lloyd G. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Lloyd G. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd G. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd G. Mitchell more than expected).

Fields of papers citing papers by Lloyd G. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd G. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd G. Mitchell. The network helps show where Lloyd G. Mitchell may publish in the future.

Co-authorship network of co-authors of Lloyd G. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd G. Mitchell. A scholar is included among the top collaborators of Lloyd G. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd G. Mitchell. Lloyd G. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mitchell, Lloyd G., et al.. (2020). Vulvar Lichen Sclerosus: Current Perspectives. SHILAP Revista de lepidopterología. 1 indexed citations
3.
McDougald, Devin S., et al.. (2018). Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA. Molecular Therapy — Nucleic Acids. 12. 294–308. 21 indexed citations
4.
Uchida, Naoya, Kareem Washington, Brian A. Mozer, et al.. (2017). RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells. Human Gene Therapy Methods. 28(2). 91–99. 4 indexed citations
5.
Uckun, Fatih M., Lloyd G. Mitchell, Sanjive Qazi, et al.. (2015). Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL. EBioMedicine. 2(7). 649–659. 10 indexed citations
6.
Koller, Ulrich, Verena Wally, Lloyd G. Mitchell, et al.. (2011). A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Research. 39(16). e108–e108. 28 indexed citations
7.
Wally, Verena, Alfred Klausegger, Ulrich Koller, et al.. (2007). 5′ Trans-Splicing Repair of the PLEC1 Gene. Journal of Investigative Dermatology. 128(3). 568–574. 55 indexed citations
8.
Mitchell, Lloyd G. & Gerard J. McGarrity. (2005). Gene Therapy Progress and Prospects: Reprograming gene expression by trans-splicing. Gene Therapy. 12(20). 1477–1485. 17 indexed citations
9.
Bhaumik, Srabani, et al.. (2004). Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing. Proceedings of the National Academy of Sciences. 101(23). 8693–8698. 32 indexed citations
10.
Mansfield, S. Gary, M. Puttaraju, Jolanta Kole, et al.. (2003). 5′ Exon replacement and repair by spliceosome-mediated RNA trans-splicing. RNA. 9(10). 1290–1297. 45 indexed citations
11.
Puttaraju, M., Lloyd G. Mitchell, Kim B. Yancey, et al.. (2003). Development of spliceosome‐mediated RNA trans‐splicing (SMaRT™) for the correction of inherited skin diseases. Experimental Dermatology. 12(1). 37–46. 43 indexed citations
12.
Mitchell, Lloyd G., Angelika Bodenteich, & Carl R. Merril. (2003). Use of Silver Staining to Detect Nucleic Acids. Humana Press eBooks. 31. 197–204. 8 indexed citations
13.
Chao, Hengjun, S. Gary Mansfield, Suja Hiriyanna, et al.. (2003). Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nature Medicine. 9(8). 1015–1019. 127 indexed citations
14.
Liu, Xiaoming, Qinshi Jiang, S. Gary Mansfield, et al.. (2002). Partial correction of endogenous ΔF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nature Biotechnology. 20(1). 47–52. 132 indexed citations
15.
Puttaraju, M., et al.. (2001). Messenger RNA Repair and Restoration of Protein Function by Spliceosome-Mediated RNA Trans-Splicing. Molecular Therapy. 4(2). 105–114. 60 indexed citations
16.
Puttaraju, M., et al.. (2000). Collagen 17A1 Gene Correction Using Spliceosome Mediated RNA Trans-splicing (SMaRT™) Technology.. Journal of Investigative Dermatology. 115(2). 332–332. 9 indexed citations
17.
Puttaraju, M., Sharon F. Jamison, S. Gary Mansfield, Mariano A. García-Blanco, & Lloyd G. Mitchell. (1999). Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nature Biotechnology. 17(3). 246–252. 151 indexed citations
18.
Werner, Mario, Michael J. Costa, Lloyd G. Mitchell, & Ritu Nayar. (1995). Nephrotoxicity of xenobiotics. Clinica Chimica Acta. 237(1-2). 107–154. 36 indexed citations
19.
Bodenteich, Angelika, Lloyd G. Mitchell, Mihael H. Polymeropoulos, & Carl R. Merril. (1992). Dinucleotide repeat in the human mitochondrial D-loop. Human Molecular Genetics. 1(2). 140–140. 25 indexed citations
20.
Mitchell, Lloyd G. & Carl R. Merril. (1989). Affinity generation of single-stranded DNA for dideoxy sequencing following the polymerase chain reaction. Analytical Biochemistry. 178(2). 239–242. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026